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Abstract
Background: Glucose homeostasis is maintained by a balance between hepatic glucose production and peripheral glucose
utilization. In skeletal muscle cells, glucose utilization is primarily regulated by glucose uptake. Deprivation of cellular energy
induces the activation of regulatory proteins and thus glucose uptake. AMP-activated protein kinase (AMPK) is known to
play a significant role in the regulation of energy balances. However, the mechanisms related to the AMPK-mediated control
of glucose uptake have yet to be elucidated.
Methodology/Principal Findings: Here, we found that AMPK-induced phospholipase D1 (PLD1) activation is required for
14C-glucose uptake in muscle cells under glucose deprivation conditions. PLD1 activity rather than PLD2 activity is
significantly enhanced by glucose deprivation. AMPK-wild type (WT) stimulates PLD activity, while AMPK-dominant negative
(DN) inhibits it. AMPK regulates PLD1 activity through phosphorylation of the Ser-505 and this phosphorylation is increased
by the presence of AMP. Furthermore, PLD1-S505Q, a phosphorylation-deficient mutant, shows no changes in activity in
response to glucose deprivation and does not show a significant increase in 14C-glucose uptake when compared to PLD1-
WT. Taken together, these results suggest that phosphorylation of PLD1 is important for the regulation of 14C-glucose
uptake. In addition, extracellular signal-regulated kinase (ERK) is stimulated by AMPK-induced PLD1 activation through the
formation of phosphatidic acid (PA), which is a product of PLD. An ERK pharmacological inhibitor, PD98059, and the PLD
inhibitor, 1-BtOH, both attenuate 14C-glucose uptake in muscle cells. Finally, the extracellular stresses caused by glucose
deprivation or aminoimidazole carboxamide ribonucleotide (AICAR; AMPK activator) regulate 14C-glucose uptake and cell
surface glucose transport (GLUT) 4 through ERK stimulation by AMPK-mediated PLD1 activation.
Conclusions/Significance: These results suggest that AMPK-mediated PLD1 activation is required for 14C-glucose uptake
through ERK stimulation. We propose that the AMPK-mediated PLD1 pathway may provide crucial clues to understanding
the mechanisms involved in glucose uptake.
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Introduction
Circulating glucose levels reflect a balance between glucose
production by the liver and glucose utilization in skeletal muscles
[1], [2]. Energy deprivation occurs when cellular glucose levels are
depleted by nutritional and environmental stressors such as
glucose starvation, pressure overload, oxidative stress or hypoxia
[3]–[8]. Once the balance breaks down, regulatory proteins such
as AMPK are stimulated to restore it. AMPK, a serine/threonine
protein kinase, is known to play an important role in the regulation
of glucose uptake [9].
AMPK is often referred to as an energy sensor because it maintains
the balance of AMP:ATP ratios and its activity increases with
decreasing levels of cellular ATP. Thus, AMPK turns on ATP-
producing catabolic pathways and turns off ATP-consuming
processes under energy deprivation conditions [10]. AMPK is a
heterotrimeric protein complex composed of one catalytic subunit (a)
and two regulatory subunits (b and c) Its activity is also regulated by
both AMP and the tumor suppressor, LKB1. Regulation by both
AMP and LKB1 accompanies the interaction with AMPK and its
phosphorylation [2]. LKB1, a serine-threonine kinase, is the most
well characterized upstream kinase for AMPK activation. LKB1
phosphorylates a conserved Thr-172 within the T-loop of the AMPK
catalytic subunit (a), leading to its activation. Activated AMPK
induces phosphorylation at the Ser-79 site of acetyl-CoA carboxylase
(ACC) as a direct downstream target. ACC regulates the conversion
of acetyl-CoA to malonyl-CoA in the de novo lipid synthesis pathway
[2]. Recently, several groups have reported that AMPKplays a major
role in the regulation of metabolic stress-induced glucose uptake in
both heart and skeletal muscles [11]–[13]. Activation of AMPK by
AICAR has also been shown to increase glucose uptake via a
phosphoinositide-3 kinase (PI-3K)-independent mechanism [14].
However, until now, the downstream target molecules of AMPK-
mediated glucose uptake have been largely unknown.
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Phospholipase D (PLD) is a ubiquitous enzyme that catalyzes
the hydrolysis of phosphatidylcholine (PC) to produce metaboli-
cally active phosphatidic acid (PA). PLDs are membrane-bound
proteins and the relative distributions of PLD isoforms (PLD1 and
PLD2) are distinct in various cell types [15]–[16]. Consistent with
its diverse locations, PLD exerts multiple cellular functions in
different cell types [17]–[19]. Previous studies have suggested that
PLD activity is regulated by various stress signals including serum
withdrawal, glucose availability, oxidative stress and pressure
overload [20]–[22]. As a result, it has been proposed that PLD
plays a role under stressful conditions. However, the regulatory
mechanisms involved in PLD activity for glucose uptake under
glucose deprivation conditions in skeletal muscle cells have not
been studied to date.
In this study, we attempted to gain insight into the relationships
between AMPK, PLD1 and glucose uptake. Based on the results of
the present study, we suggest that AMPK-induced PLD1 activity is
required for the regulation of glucose uptake via ERK activation in
muscle cells and that PLD1 has a novel site that is phosphorylated
by AMPK. Taken together, these findings imply that the AMPK-
PLD1 pathway may contribute to the control of glucose
homeostasis.
Results
AMPK Stimulates PLD1 Activity
Previous studies have shown that PLD activity was regulated
when energy imbalance was induced by serum withdrawal or
glucose starvation [22], [23]. To determine the specific role of
PLD isoforms under glucose deprivation, we examined PLD
activity after the ectopic expression of PLD1 or PLD2 isoforms in
HEK-293 cells. Endogenous PLD activity led to a significant
increase in vector-transfected cells under glucose deprivation, as
indicated by increased byproducts (PBtOH) of PLD-mediated
transphosphatidylation (Figure 1A). PLD1 activity increased
approximately 2-fold in PLD1-transfected cells under glucose
deprivation conditions, whereas PLD2 activity changed very
slightly under the same conditions (Figure 1A). Since, it is well
known that AMPK is regulated by changes in the physiological
glucose concentration [4], [9], we investigated the relationship
between PLD isoforms and AMPK under different glucose
concentrations. We first silenced PLD1 or PLD2 in HEK-293
cells and then examined PLD activity. As shown in Figure 1B,
endogenous PLD1 activity was enhanced in PLD2-silenced cells
in response to decreasing glucose concentrations, whereas
endogenous PLD2 activity was unaffected in PLD1-silenced cells.
The expression levels of PLD, AMPK, pACC (Ser-79) and
pAMPK (Thr-172) were analyzed by western blotting. pACC
(Ser-79) and pAMPK (Thr-172) were used as positive controls to
show the activation of AMPK pathway induced by glucose
deprivation. Figure 1A shows that PLD2 had a higher basal
activity (1.6-fold) than PLD1 in the presence of glucose (25 mM)
when PLD isoforms were overexpressed in HEK-293 cells. As
shown in Figure 1B, endogenous PLD2 activity in PLD1 siRNA-
transfected cells was also higher than endogenous PLD1 activity
in PLD2 siRNA-transfected cells in the presence of both 25 mM
and 12.5 mM glucose. Substantially, the basal activities of both
PLD1 and PLD2 are quite different since there are distinct
regulatory mechanisms of PLD isoforms. Additionally, it has
previously been shown that the conditions used in Figure 1A and
B do not lead to saturation of PLD2 isoform. Therefore, these
results indicate that the activity of PLD1, but not that of PLD2, is
inversely dependent upon the glucose concentration. Further-
more, to determine if the stimulation of PLD is regulated by
AMPK activity, we infected HEK-293 cells with AMPK
adenoviruses using AMPK-wild type (WT) and AMPK-dominant
negative (DN). In control adenovirus-infected cells, PLD activity
significantly increased when glucose was deprived. In AMPK-
WT adenovirus-infected cells, PLD activity increased approxi-
mately 1.8-fold in the presence of glucose when compared to
control adenovirus-infected cells. Under glucose deprivation,
PLD activity increased about 1.7-fold in AMPK-WT, whereas no
change in the PLD activity in AMPK-DN was observed
(Figure 1C). These results suggest that PLD activity is regulated
by AMPK activation.
AMPK Directly Phosphorylates PLD1
To delineate the regulatory mechanism of PLD1 by AMPK,
we performed co-immunoprecipitation experiments using HEK-
293 cells, which express PLD1 as a major isoform. When 2-
deoxyglucose (2-DOG) was used as a glucose mimic to induce
ATP depletion, endogenous PLD was physically associated with
AMPK in a 2-DOG-dependent manner (Figure 2A). To
determine if AMPK directly phosphorylates PLD1, we incubated
PLD1 and AMPK with or without AMP. As shown in Figure 2B,
AMPK phosphorylated the purified PLD1 in vitro. Specifically,
AMPK enhanced the phosphorylation of PLD1 in the presence of
AMP. However, AMPK was unable to phosphorylate the purified
PLD2 directly in the presence of AMP (data not shown). To
verify the potential phosphorylation sites, we performed in vitro
phosphorylation assays using GST-truncated PLD1 fusion
mutants. Figure 2C demonstrates that the F3 fragment corre-
sponding to amino acid region 499–604 was specifically
phosphorylated by AMPK in the presence of AMP. Based on
this finding, we surveyed the candidate phosphorylation sites of
the PLD1-loop corresponding to the 499–604 amino acid region
by comparing it with an AMPK consensus motif. Interestingly,
the PLD1-loop contained two candidate phosphorylation sites
including the Ser-505 and the Ser-558 residues (Figure 2D).
However, no possible phosphorylation sites were observed in the
corresponding region of the PLD2 sequence because the central
loop is a unique region of PLD1. To define the phosphorylation
sites of PLD1, we generated several constructs including PLD1-
S505A, PLD1-S505Q and PLD1-S558A. As shown in quantified
results of Figure 2E, both PLD1-WT and PLD1-S558A were
phosphorylated by AMPK in the presence of AMP whereas both
PLD1-S505A and PLD1-505Q were not phosphorylated under
the same conditions. We also utilized AMPK adenovirus to
determine if AMPK phosphorylates PLD1 on the Ser-505 residue
in vivo. After treatment with 2-DOG, PLD1 was phosphorylated
by AMPK-WT, whereas PLD1-S505Q remained unphosphory-
lated (Lane 3 and 4 in Figure 2F). These findings demonstrate
that AMPK phosphorylates PLD1 on the Ser-505 residue in vivo.
Based on these results, we suggest that PLD1 may be a novel
substrate of AMPK.
AMPK Regulates PLD1 Activity through Phosphorylation
To determine if PLD1 activity is substantially regulated by
phosphorylation, we measured the PLD1 activity using several
PLD1-mutants including PLD1-WT, S505Q, S505E and S558A
in the presence or absence of 25 mM glucose. As shown in
Figure 3A, PLD1-WT activity was stimulated by the removal of
glucose, whereas PLD1-S505Q activity was not. PLD1-S505Q still
showed a basal level of activity similar to that of PLD1-WT in the
presence of glucose. However, PLD1-S505A had no basal activity,
regardless of the glucose concentrations (data not shown). These
results indicate that the substitution of Ser to Ala on the Ser-505
residue is related to the basal activation of PLD1. In addition,
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PLD1-S505E displayed much higher activity than PLD1-S505Q,
regardless of the glucose concentrations. PLD1-S558A activity
increased by approximately 2.2-fold under glucose deprivation
conditions. PLD1-WT activity enhanced about 2.1-fold under the
same conditions. Based on these findings, the Ser-558 residue of
PLD1 does not appear to be a regulatory site that is
phosphorylated by AMPK. To confirm that PLD1 activity is
regulated by ATP depletion, we measured the PLD1 activity after
treatment with 2-DOG. As shown in Figure 3B, the PLD1-WT
activity was stimulated by ATP depletion induced by 2-DOG, but
PLD1-S505Q was unaffected under the same conditions. Taken
together, these results suggest that AMPK stimulates PLD1 activity
through phosphorylation of the Ser-505 residue under glucose
deprivation.
Figure 1. The effects of glucose deprivation on PLD activity. A. HEK-293 cells were transfected with the indicated plasmids for vector, PLD1 or
PLD2. At 40 h after transfection, cells were incubated in glucose free-DMEM with or without 25 mM glucose for 2 h. Cells were then labeled with
[3H]myristric acid for 4 h and the formation of [3H]PBtOH was quantified as described in the materials and methods. Quantitative data represent the
means of three independent experiments. *, p,0.05 versus vector-transfected cells with glucose; #, p,0.05 versus vector-transfected cells without
glucose. B. HEK-293 cells were transfected with siRNAs for PLD1, PLD2 or control (Luciferase). At 40 h after transfection, cells were incubated in
glucose free-DMEM with the indicated concentrations of glucose (25 mM [4.5 g/L], 12.5 mM [2.25 g/L], 6.25 mM [1.125 g/L]) for 2 h. Cells were then
labeled with [3H]myristric acid for 4 h and the formation of [3H]PBtOH was quantified. The expression levels of PLD and AMPK were analyzed by
western blotting using antibodies directed against PLDs or AMPK. pACC (Ser-79) and pAMPK (Thr-172) were used as positive controls to show the
activation of AMPK pathway induced by glucose deprivation. Actin was used as a loading control. Quantitative data represent the means of three
independent experiments. *, p,0.05 versus control siRNA-transfected cells in the presence of glucose; #, p,0.05 versus control siRNA-transfected
cells in the absence of glucose. C. HEK-293 cells were infected with control (empty vector), AMPK-WT or AMPK-DN adenovirus. At 40 h after infection,
cells were incubated in glucose free-DMEM with or without 25 mM glucose for 2 h. Cells were labeled with [3H]myristric acid for 4 h and the
formation of [3H]PBtOH was then quantified. Data represent the means of three independent experiments. *, p,0.05 versus control adenovirus-
infected cells with glucose; #, p,0.05 versus control adenovirus-infected cells without glucose.
doi:10.1371/journal.pone.0009600.g001
PLD1 Regulation by AMPK
PLoS ONE | www.plosone.org 3 March 2010 | Volume 5 | Issue 3 | e9600
PLD1 Regulation by AMPK
PLoS ONE | www.plosone.org 4 March 2010 | Volume 5 | Issue 3 | e9600
AMPK-Induced PLD1 Activation Is Required for ERK
Stimulation
Based on the finding that AMPK stimulates PLD1 through
direct phosphorylation (Figures 1 and 2), we investigated the
downstream target molecules of AMPK-induced PLD1 activation
to determine the reasons for PA formation. Previous studies have
found that the activation of PLD may implicate the mitogen
activated protein kinase (MAPK) pathway through raf-1 activation
via recruitment of PLD-generated PA binding [24], [25]. We
attempted to determine if stimulation of ERK is regulated by PLD
activity under glucose deprivation conditions. To accomplish this,
we utilized 1-butanol (1-BtOH) as an inhibitor of PLD and t-
butanol (t-BtOH) as a negative control in the presence or absence
of glucose. 1-butanol was used to prevent generation of the PLD
products, PA. ERK activation, which was determined based on an
increase in the phosphorylated ERK levels, was dramatically
increased by glucose deprivation in both NT (not treated)-cells and
t-BtOH-treated cells (Figure 4A). However, ERK activation was
very slightly increased in 1-BtOH-treated cells under the same
conditions. In the absence of glucose, ERK activation was
attenuated in 1-BtOH-treated cells when compared to both NT-
cells and t-BtOH-treated cells. pACC (Ser-79) was used as a
positive control to show the activation of the AMPK pathway
induced by glucose deprivation. These results indicate that PLD
activation is required for ERK activation. To elucidate the effects
of PLD1-generated PA on ERK activation, we silenced PLD1 with
siRNA and then treated the cells with various concentrations of
exogenous PA. As shown in Figure 4B, ERK activation was
attenuated in PLD1 siRNA-transfected cells when compared to
control siRNA-transfected cells. In addition, exogenous PA
increased ERK activation in a dose dependent manner. These
results imply that PA supplied by PLD activation is responsible for
ERK activation. Next, we examined the specificity of ERK
activation by the presence of various extracellular stressors
including 2-DOG, mannitol and H2O2. ERK activation was
reduced in PLD1 siRNA-transfected cells in response to 2-DOG
when compared to control siRNA-transfected cells (Figure 4C). To
exclude the influence of nonspecific 2-DOG by hyperosmolar
stress, we utilized mannitol as a negative control to induce
hyperosmolar stress. As shown in Figure 4D, ERK activation was
slightly increased in PLD1 siRNA-transfected cells in response to
treatment with mannitol when compared to control siRNA-
transfected cells. These results imply that PLD1 activation induced
by energy depletion but not hyperosmolar stress is required for
ERK activation. H2O2 used as a positive control to induce
oxidative stress also resulted in a reduction of ERK activation in
PLD1 siRNA-transfected cells when compared to control siRNA-
transfected cells (Figures 4E). To confirm the effects of PLD lipase
activity on ERK activation, we included another construct, PLD1-
K860R, which is a lipase-inactive mutant. As shown in Figure 4F,
PLD1-WT showed approximately 3.3-fold greater levels of ERK
activation in response to 2-DOG and about 4.2-fold greater ERK
activation following H2O2 treatment. The ERK activation
observed in PLD1-WT was similar to the activation observed in
PLD1-S505Q under basal conditions (Lanes 1 and 4). PLD1-
S505Q also showed approximately 1.1-fold greater levels of ERK
activation in response to treatment with 2-DOG and about 2-fold
greater ERK activation following H2O2 treatment. PLD1-K860R
showed decreased ERK activation under basal conditions when
compared to PLD1-WT (Lanes 1 and 7). PLD1-K860R showed
very slightly higher ERK activation, despite treatment with 2-
DOG or H2O2. Based on these observations, we suggest that ERK
activation is dependent on PLD1 activity in response to 2-DOG or
H2O2. Therefore, these results imply that AMPK-mediated PLD1
activation contributes to the stimulation of ERK under energy
depletion conditions caused by glucose deprivation and oxidative
stress.
AMPK-Induced PLD1 Activation Is Important for
14C-Glucose Uptake in Differentiated C2C12 and L6
GLUT4-myc Myotube Cells
Previous studies have reported that AMPK activity is involved
in glucose homeostasis in a variety of cells [1], [10], and that PLD
activity is required for glucose uptake in muscles and adipocytes
[21], [23], [26]. Based on these previous findings, we investigated
the mechanisms by which AMPK and PLD regulate the glucose
uptake using 2-deoxy[14C-glucose] as an indicator for the glucose
uptake assay. As shown in Figure 5A, PLD1-WT showed an
approximately 2.8-fold increase in 14C-glucose uptake in the
presence of glucose when compared to vector-transfected cells
(Columns 1 and 2). PLD1-S505Q showed about 2.7-fold greater in
14C-glucose uptake under the same conditions (Columns 1 and 3).
Figure 2. AMPK phosphorylates PLD1 but not PLD2. A. After treatment with 25 mM 2-DOG for 10 min, HEK-293 cells were lysed with buffer
containing 1% Triton X-100 and 1% cholic acid. After determination of the total protein concentrations, equal amounts of extracts were
immunoprecipitated with anti-PLD antibody. After brief centrifugation and washing, the precipitates were subjected to SDS-PAGE and
immunoblotted with anti-PLD and anti-AMPK antibodies. The total lysates show approximately 1% of the proteins used for immunoprecipitation. B.
AMPK was incubated with purified PLD1 (100 ng) in kinase buffer A (50 mM Tris/HCl, pH 7.4, 1 mM dithiothreitol, 0.02% Brij-35 and 10 mCi of
[c-32P]ATP (3,000 Ci/mmol)) in the presence or absence of AMP (200 nM). This reaction was terminated by the addition of SDS sample buffer. The
precipitates were then subjected to SDS-PAGE and exposed to photographic film for autoradiography. Ponceau S staining shows the protein
amounts in each sample. C. GST-truncated PLD1 fusion mutants were expressed in bacteria and then purified using glutathione sepharose beads.
The truncated PLD1 mutants were followed by F1 (amino acid [a.a.] 1 to 331), F2 (a.a. 332 to 498), F3 (a.a. 499 to 604), F4 (a.a. 605 to 712), F5 (a.a. 713
to 825), F6 (a.a. 826 to 927) and F7 (a.a. 928 to 1036). AMPK was incubated with an equal amount of each GST-truncated PLD1 fusion mutants (1 mg)
in kinase buffer A in the presence of AMP (200 nM). This reaction was terminated by the addition of SDS sample buffer and exposed to photographic
film for autoradiography. D. Schematic diagram of the PLD1 sequences. Human PLD1 sequences corresponding to the loop region were aligned with
those of rat and mouse. Candidate phosphorylation sites of PLD1 for AMPK are shown in the boxes. E. HEK-293 cells were transfected with the
indicated plasmids for vector, PLD1-WT, S558A, S505Q or S505A. At 48 h after transfection, cells were lysed with buffer and the lysates were
immunoprecipitated with anti-PLD antibody. After brief centrifugation and washing, AMPK was incubated with the PLD1-immunocomplexes in
kinase buffer A. This reaction was terminated by the addition of SDS sample buffer and the precipitates were then subjected to SDS-PAGE and
exposed to photographic film for autoradiography. The relative intensity of the autoradiogram was quantified as described in the materials and
methods. The data shown represent one of three independent experiments. Bar graphs reflect the average of three independent experiments. *,
p,0.05 versus vector-transfected cells. F. HEK-293 cells were transfected with the indicated plasmids of PLD1-WT or PLD1-S505Q. At 24 h post-
transfection, cells were infected with control (empty vector), AMPK-WT or AMPK-DN adenovirus. At 24 h after infection, cells were loaded with [32P]
orthophosphate (3 mCi/ml) for 5 h and then treated with 25 mM of 2-DOG for 10 min. Next, the extracts were prepared with lysis buffer and
immunoprecipitated with anti-PLD antibody. After brief centrifugation and washing, the precipitates were then subjected to SDS-PAGE, transferred to
nitrocellulose membranes and exposed to photographic film for autoradiography. The expression levels of AMPK and PLD1 were analyzed by western
blotting and ponceau S staining. Data represent one of three independent experiments.
doi:10.1371/journal.pone.0009600.g002
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PLD1-WT showed an approximately 1.9-fold increase in 14C-
glucose uptake under glucose deprivation conditions (Columns 2
and 5), while PLD1-S505Q showed only a 1.2-fold increase in
14C-glucose uptake under the same conditions (Columns 3 and 6).
The changes in 14C-glucose uptake in response to glucose
deprivation showed a similar pattern to that of PLD1 activity.
These results indicate that the Ser-505 residue of PLD1 is required
for 14C-glucose uptake in response to glucose deprivation. Next,
we measured the 14C-glucose uptake in response to AICAR (used
as an AMPK activator) and AMPK-DN to determine the effects of
AMPK on glucose uptake. As shown in Figure 5B, the 14C-glucose
uptake was increased by about 1.9-fold by AICAR, but was
significantly reduced by AMPK-DN (Columns 2 and 3). To
examine the effects of PLD and ERK on glucose uptake, we
treated the cells with 1-BtOH (a PLD inhibitor) and PD98059 (an
ERK inhibitor). The 14C-glucose uptake was attenuated in
response to treatment with 1-BtOH as well as PD98059.
Furthermore, the increase in 14C-glucose uptake regulated by
AICAR was correlated with that of the 14C-glucose uptake
induced by glucose deprivation (Columns 2 and 7). The increase in
14C-glucose uptake induced by glucose deprivation was decreased
by AMPK-DN, 1-BtOH and PD98059 (Columns 8, 9 and 11).
Taken together, these results imply that AMPK-PLD1-induced
ERK activation is necessary for glucose uptake in differentiated
C2C12 cells. To further define the role of ERK activation in
glucose uptake, we investigated the amount of cell surface glucose
transport (GLUT) 4 and the 14C-glucose uptake in differentiated
L6 GLUT4-myc myotube cells. The levels of cell surface GLUT4
were enhanced by about 1.5-fold by glucose deprivation when
compared to the presence of glucose. AICAR increased the
amount of cell surface GLUT4 by approximately 1.8-fold.
However, the levels of cell surface GLUT4 induced by both
glucose deprivation and AICAR were attenuated by the presence
of PD98059 (Figure 5C). As shown in Figure 5D, glucose
deprivation increased the 14C-glucose uptake by approximately
1.6-fold in the absence of PD98059 when compared to the
presence of 25 mM glucose (Columns 1 and 2). AICAR enhanced
the 14C-glucose uptake by about 1.5-fold under the same
conditions (Columns 1 and 3). However, the 14C-glucose uptake
stimulated by both glucose deprivation and AICAR were
attenuated by the presence of PD98059. Taken together, these
results suggest that the stimulation of ERK is required for glucose
uptake in differentiated L6 GLUT4-myc myotube cells.
Discussion
Although it is known that extracellular stressors such as AICAR
increase glucose uptake through the AMPK pathway in muscle
cells, the downstream aspects of AMPK signaling are largely
unknown. In the present study, we found that PLD1 is a novel
signaling effector of AMPK. Several lines of evidence support the
notion that PLD1-mediated AMPK activation is required for
ERK activation and glucose uptake in muscle cells (Figure 5E). For
example, AMPK stimulates PLD1 through phosphorylation as
demonstrated by a reduction of PLD1 activity in AMPK-DN
adenovirus-infected cells (Figure 1). Moreover, mutagenesis and in
vitro and in vivo phosphorylation assays demonstrated that AMPK
phosphorylates PLD1 on the Ser-505 (Figure 2). ERK activation
was found to be dependent on energy status, but not hyperosmolar
stresses (Figure 4). Finally, ERK activation by AMPK-mediated
PLD1 was found to be essential for 14C-glucose uptake in
differentiated C2C12 and L6 GLUT4-myc myotube cells
(Figure 5). Taken together, these results suggest that PLD1 is a
downstream effector of AMPK in a signaling pathway related to
Figure 3. Activity of PLD1-WT and PLD1-mutants under
glucose deprivation. A. HEK-293 cells were transfected with the
indicated plasmids of vector, PLD1-WT, S558A, S505Q or S505E. At 40 h
after transfection, cells were incubated in glucose free-DMEM with or
without 25 mM glucose for 2 h. PLD activity in each group was then
measured by the formation of [3H]PBtOH. The expression levels of PLD1
were analyzed by western blotting. Quantitative data represent the
means of four independent experiments. *, p,0.01 versus vector-
transfected cells with glucose; #, p,0.01 versus vector-transfected cells
without glucose. B. HEK-293 cells were transfected with siRNAs directed
against PLD. At 24 h post-transfection, cells were transfected with
siRNA-resistant forms of the indicated PLD1 [45]. After 24 h, cells were
treated with 25 mM of 2-DOG for 10 min and the formation of
[3H]PBtOH was then quantified as previously described. Re-expression
levels of PLD1 were analyzed by western blotting. Quantitative data
represent the means of three independent experiments. *, p,0.01
versus vector-transfected cells without 2-DOG;#, p,0.01 versus vector-
transfected cells with 2-DOG.
doi:10.1371/journal.pone.0009600.g003
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glucose uptake under glucose deprivation conditions in muscle
cells, C2C12 and L6 GLUT4-myc myotube cells. Understanding
the molecular mechanism involved in glucose uptake may provide
insight into the regulation of glucose homeostasis and shed light on
diseases related to type 2 diabetes.
Emoto and Huang previously reported that the expression of
PLD1 facilitates insulin-stimulated glucose uptake in 3T3L1
adipocytes [26], [27]. However, their studies were limited in that
they did not identify the upstream regulator of PLD1 and its roles
were only studied in adipocytes. In general, muscle is known to
respond to acute and transient glucose deprivation, while adipose
tissue responds to chronic reactions. In the present study, we
demonstrated that PLD1 phosphorylation is responsible for acute
signaling mechanisms in muscle cells and that AMPK is a novel
regulator of PLD1 that functions in a glucose dependent manner.
Despite extensive research on upstream stimuli that activate
AMPK, few studies have been conducted to investigate the
downstream substrate(s) of AMPK-mediated glucose uptake.
Acetyl-coA carboxylase (ACC) is a well-known AMPK substrate
that is involved in lipid metabolism. Recent reports have revealed
that AS 160, which is a known substrate for AKT, is also a
downstream molecule of AMPK in contraction-stimulated glucose
uptake [28-30]. However, the recent identification of multiple
functions of AMPK in energy sensing pathways indicates that it
plays a more comprehensive role in such pathways. In this study,
energy-deficient conditions mimicked by glucose deprivation
induced AMPK activation, which subsequently stimulated PLD1
lipase activity. This AMPK-mediated PLD1 activity was involved
in glucose uptake under energy-depleted conditions (Figure 5).
Taken together, these findings indicate that AMPK activity driven
by contraction can regulate AS 160 and that AMPK stimulation
induced by glucose deprivation may control PLD1. However,
further investigations are needed to determine how two different
effectors, AS 160 and PLD1, are distinguished by AMPK in
response to specific stimuli.
AMPK plays a pivotal role in the maintenance of glucose
homeostasis, showing strong responses to glucose deprivation in
muscle cells. AMPK is known to have a well-conserved consensus
motif for phosphorylation. It has been reported that PLD activity
is regulated through phosphorylation or protein-protein interac-
tion [2], [9]. In this study, we demonstrated for the first time that
the phosphorylation of PLD1 by AMPK is important for its
activity (Figure 3). The PLD1-loop region corresponding to amino
acids 499–604 is directly phosphorylated by AMPK (Figure 2C)
and the phosphorylation sites for AMPK are only observed in the
PLD1 sequence because the loop region is a unique characteristic
of PLD1. We investigated the phosphorylation sites of the PLD1-
loop region using the AMPK consensus motif, [IMLVP or
hydrophobic]-X-[HRK]-X-X-[ST]-X-X-X-[IMLVP or hydro-
phobic], through a site scan and a BLAST search [31–34].
Throughout the immunoprecipitation assays and in vitro and in vivo
phosphorylation assays, we found that the PLD1-loop region had
two phosphorylation sites and one of them (the Ser-505 residue) is
actually phosphorylated by AMPK (Figures 2E and F). Although
many investigators have suggested that the PLD isoforms have
different regulatory mechanisms due to their different structures,
the specific role of the PLD1-loop region has not yet been defined.
Here, we identified the phosphorylation site within the PLD1-loop
region that regulates PLD1 activity and is involved in AMPK-
mediated glucose uptake. However, additional studies may be
necessary to characterize the distinct roles of the PLD1-loop
region in various cell types.
Insulin is known to stimulate glucose uptake in the skeletal
muscle cells through PI-3K-dependent AKT activation. However,
glucose uptake following extracellular stresses such as glucose
deprivation and AICAR has been reported to occur independently
of AKT [3], [29], [35]. Despite these reports, the detailed signaling
pathway through which glucose uptake occurs in response to
extracellular stress has not yet been clarified. Farese et al. showed
that the activation of AMPK by AICAR induces stimulation of
ERK, which belongs to the MAPK family, through a specific
pathway [21], [23]. In the present study, western blotting and gene
silencing with PLD1-siRNA revealed that AMPK-mediated PLD1
activity results in the generation of PA and that PLD1 stimulates
ERK activity in response to glucose deprivation (Figure 4). PA has
been reported to stimulate the MAPK pathway through the
recruitment of raf-1 to the membrane. In addition, AMPK
stimulated by AICAR, oxidative stress (H2O2) or glucose
deprivation has been found to be associated with activation of
the MAPK pathway [36–38]. These data appear to explain the
difference between the two distinct coupled signaling pathways,
insulin-AKT activation and glucose deprivation-ERK stimulation.
Figure 4. The effects of PLD1 on ERK activation by various stimuli. A. After HEK-293 cells were incubated in glucose free-DMEM with or
without 25 mM glucose for 2 h, cells were treated with 1-BtOH or t-BtOH for 15 min and then lysed with lysis buffer. Cell lysates were then analyzed
by western blotting with the indicated antibodies. pACC (Ser-79) was used as a positive control to show the activation of AMPK pathway induced by
glucose deprivation. Actin was used as a loading control. These data represent the mean of three independent analyses. B. HEK-293 cells were
transfected with the indicated siRNAs of control (Luciferase) or PLD1. At 48 h after transfection, cells were incubated in glucose free-DMEM with or
without 25 mM glucose and the indicated concentrations of exogenous PA for 2 h. Cells were harvested and then lysed with lysis buffer. pACC (Ser-
79) was used as a positive control and the protein amounts were normalized against actin. Cell lysates were subjected to SDS-PAGE and analyzed by
western blotting with the indicated antibodies. These data represent one of three experiments in independent analyses. C. HEK-293 cells were
transfected with the indicated siRNAs of control (Luciferase) or PLD1. At 48 h after transfection, cells were treated with the indicated concentrations
of 2-DOG for 10 min. Then, cells were lysed with lysis buffer and lysates were subjected to SDS-PAGE and then immunoblotted with the indicated
antibodies. pACC (Ser-79) was used as a positive control to show the activation of the AMPK pathway induced by treatment with 2-DOG. Actin was
used as a loading control for western blotting. The data shown represent one of three independent experiments. D. HEK-293 cells were transfected
with the indicated siRNAs for control (Luciferase) or PLD1. At 48 h after transfection, cells were treated with the indicated concentrations of mannitol
as a negative control to induce hyperosmolar stress for 10 min. Cells were prepared according to the methods described in panel A and cell lysates
were then immunoblotted with the indicated antibodies. These data shown are from one of three independent experiments. E. HEK-293 cells were
transfected with the indicated siRNAs of control (Luciferase) or PLD1. At 48 h after transfection, cells were treated with the indicated concentrations
of H2O2 for 10 min as a positive control to induce oxidative stress. Cells were prepared according to the methods described in panel A and cells
lysates were then immunoblotted with the indicated antibodies. pACC (Ser-79) was used as a positive control to show the activation of the AMPK
pathway induced by H2O2 treatment. Actin was used as a loading control for western blotting. These data shown are from one of three independent
experiments. F. HEK-293 cells were transfected with the indicated plasmids for PLD1-WT, PLD1-S505Q or PLD1-K860R. At 48 h after transfection, cells
were treated with 25 mM of 2-DOG or 0.2 mM of H2O2 for 10 min. Cell lysates were prepared as described in A and then immunoblotted with the
indicated antibodies. pERK activation was normalized against the expression of ERK. The relative intensity of pERK was quantified as described in the
materials and methods. The data shown represent one of three independent experiments. Bar graphs reflect the average of three independent
experiments. *, p,0.05 versus PLD1-WT-transfected cells.
doi:10.1371/journal.pone.0009600.g004
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However, further studies are necessary to characterize the
specificity of the signaling pathways.
In this study, we demonstrated that ERK stimulated by AMPK-
induced PLD1 activation regulates the translocation of GLUT4 in
L6 GLUT4-myc myotube cells. Several groups have reported that
ERK activation is required for increased glucose uptake through
the cell surface translocation of GLUT4 by AICAR [23], [39].
PLD1 isoform is involved in the translocation of GLUT4 and
PLD1-induced PA generation is also required for the trafficking
mechanisms of GLUT4 during membrane fusion and docking
[26]. Based on these previous reports and the results of the present
study, we suggest that the AMPK-mediated PLD1 pathway
increases glucose uptake through regulation of the translocation
machinery of GLUT4. However, the mechanism by which ERK
regulates the translocation machinery of GLUT4 is still not clear.
In conclusion, we suggest that AMPK-mediated PLD1 activity is
essential for glucose uptake via ERK activation in differentiated
C2C12 and L6 GLUT4-myc myotube cells. PLD1 and its
phosphorylation may serve as important points in the regulation
of energy exhaust caused by both glucose deprivation and
extracellular stresses. Accordingly, we suggest that the physiological
interaction between AMPK and PLD1 may provide clues to solving
problems in metabolic syndromes such as diabetes. The AMPK-
mediated PLD1 pathway may provide attractive target molecules
for prospective pharmacological studies or genetic manipulation.
However, further studies are necessary to understand the
relationship between this signaling cascade and related diseases.
Materials and Methods
Materials
An enhanced chemiluminescence kit (ECL system) and
glutathione Sepharose 4B were purchased from Amersham
Pharmacia Biotech. Protease inhibitor cocktail, 2-deoxyglucose
(2-DOG), mannitol and o-phenylenediamine dihydrochloride
were obtained from Sigma. Polyclonal anti-pAMPK antibody
(Thr-172), anti-pERK (Thr-202/Tyr-204) antibody and anti-ERK
antibody were purchased from Cell Signaling. AMPK, anti-
AMPK antibody and polyclonal anti-pACC antibody (Ser-79)
were obtained from Upstate Biotechnology, Inc. Anti-actin
antibody was obtained from ICN Pharmaceuticals. b-octylgluco-
pyranoside and PD98059 were purchased from Calbiochem.
Horseradish peroxidase-conjugated goat anti-rabbit IgG and goat
anti-mouse IgA, IgM and IgG were obtained from Kirkegaard &
Perry Laboratories. [c-32P]ATP, [3H]myristic acid and [32P]or-
thophosphate were purchased from Perkin-Elmer Life Sciences.
C6-phosphatidic acid (PA) was obtained from Avanti Lipids Inc. 2-
deoxy[14C-glucose] was acquired from ARC. Immobilized protein
A was purchased from Pierce. Glucose free-Dulbecco’s modified
Eagle’s medium (DMEM), phosphate free-DMEM and a-MEM
were obtained from Life Technologies, Inc. Polyclonal antibody
for the recognition of PLD1 and PLD2 was generated as
previously described [40].
Purification of Recombinant PLD from sf9 Cells
Hexa-histidine (His6)-tagged PLD was expressed in sf9 cells and
then purified by Chelating Sepharose-affinity column chromatog-
raphy, which was performed as previously described [40].
Cell Culture, Differentiation and Transfection
HEK-293 cells and C2C12 cells were obtained from American
Type Culture Collection (ATCC) and were maintained according
to the standard ATCC protocol. HEK-293 cells and C2C12 cells
were supplemented with 10% (v/v) fetal bovine serum (FBS) at
37uC in a humidified, CO2-controlled (5%) incubator. L6
GLUT4-myc myoblast cells were grown in a-MEM containing
10% fetal bovine serum, 50 U of penicillin/ml and 50 mg of
streptomycin/ml and then maintained in a 5% CO2 humidified
atmosphere at 37uC. To induce myogenic differentiation, C2C12
cells were grown to 70–90% confluency and then shifted from
growth medium (DMEM + 10% FBS) to differentiation medium
(DMEM + 2% horse serum). To induce differentiation of L6
GLUT4-myc myoblast cells, cells were diluted to a concentration
of 46104/ml with a-MEM medium containing 2% FBS and then
seeded in a 24 well plate. The plate was then incubated in a 5%
CO2 humidified atmosphere at 37uC and the medium was
changed every other day. After 7 days, L6 GLUT4-myc myoblast
cells had differentiated into myotubes. HEK-293 cells were
transfected using Lipofectamine and C2C12 cells were transfected
with Lipofectamine 2000 to induce transient expression of the
indicated plasmids and siRNAs.
siRNA Sequences
The small interfering RNAs (siRNA) for PLD1, PLD2 or
controls (Luciferase) were purchased from Dharmacon Research,
Figure 5. Glucose uptake in differentiated C2C12 and L6 GLUT4-myc myotube cells. A. C2C12 cells were transfected with PLD siRNAs. At
24 after transfection, cells were transfected with the indicated siRNA-resistant PLD1 plasmids for vector, PLD1-WT or PLD1-S505Q [45]. After 24 h, cells
were incubated in glucose free-DMEM with or without 25 mM glucose for 2 h. The expression levels of PLD1 were then analyzed by western blotting.
The amounts of 14C-glucose uptake and [3H]PBtOH formation were analyzed as described in the materials and methods. The quantitative data shown
represent the means of three independent experiments. *, #, p,0.05 versus vector-transfected cells with glucose; ", 1, p,0.05 versus vector-
transfected cells without glucose. B. After C2C12 cells were differentiated according to the procedures described in the materials and methods, cells
were incubated in glucose free-DMEM with or without 25 mM glucose for 2 h. Cells were then treated with the indicated exogenous agents (AICAR [1
mM], 1-BtOH [0.4%], t-BtOH [0.4%], PD98059 [20 mM]) for 30 min. For the case of infection of AMPK-DN adenovirus, the differentiated C2C12 cells
were incubated with the virus for 48 h. Cells were then incubated in glucose free-DMEM with or without 25 mM glucose for 2 h and were treated with
1 mM of AICAR for 15 min. The uptake of 14C-glucose was measured and quantified. The quantitative data shown represent the means of four
independent experiments. *, p,0.05 versus vehicle treatment in the presence of glucose; #, p,0.05 versus vehicle treatment in the absence of
glucose. C. L6 GLUT4-myc myoblast cells were differentiated according to the procedures described in the materials and methods. The differentiated
L6 GLUT4-myc myotube cells were incubated in glucose free-DMEM with or without 25 mM glucose for 2 h or pre-treated with 1 mM AICAR for 30
min. After treatment with 20 mM of PD98059 for 30 min, the amount of cell surface GLUT4 was quantified as described in the materials and methods.
This experiment was performed as three independent assays. *, p,0.01 versus vehicle treatment in the presence of 25 mM glucose;#, p,0.01 versus
PD98059 treatment in the presence of 25 mM glucose. D. The differentiated L6 GLUT4-myc myotube cells were incubated in glucose free-DMEM with
or without 25 mM glucose for 2 h or pre-treated with 1 mM AICAR for 30 min. After treatment with 20 mM of PD98059 for 30 min, the uptake of 14C-
glucose was measured and quantified. Quantitative data represent the means of three independent experiments. *, p,0.01 versus vehicle treatment
in the presence of 25 mM glucose; #, p,0.01 versus PD98059 treatment in the presence of 25 mM glucose. E. A hypothetical model. This diagram
shows a hypothetical model of extracellular stress-mediated glucose uptake. Glucose uptake is induced by the AMPK-activated signaling pathway. In
this pathway, AMPK increases PLD1 activity through phosphorylation and promotes glucose uptake by triggering subsequent ERK activation in
muscle cells.
doi:10.1371/journal.pone.0009600.g005
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Inc. and used as previously described [41]. The results of a BLAST
search of all siRNA sequences revealed no significant homology
with any other sequences in the database program.
Construction and Preparation of GST Fusion Proteins
GST fusion proteins of PLD1 were generated as previously
described [41]. The individual fragments of PLD1 were then
amplified by PCR using specific primers. They were digested with
the restriction enzymes EcoRI and XhoI and ligated into pGEX-
4T1 vector. Next, E. coli BL21 cells were transformed with
individual expression vectors encoding the GST fusion proteins
and expression was then induced by culture in the presence of
0.5 mM isopropyl-b-D-thiogalactopyranoside (IPTG) at 25uC for
4 h. After harvesting cells, GST fusion proteins of PLD1 were
purified as previously described [41].
Co-Immunoprecipitation
HEK-293 cells were cultured, harvested and lysed with PLD
assay buffer (50 mM Hepes/NaOH, pH 7.4, 3 mM EGTA,
3 mM CaCl2, 3 mM MgCl2 and 80 mM KCl) containing 1%
Triton X-100, 1% cholic acid, 1 mM PMSF and protease
inhibitor cocktail. After brief sonication, lysates were centrifuged
at 100,0006g for 30 min and the supernatants (2 mg) were then
incubated with anti-PLD-conjugated protein A Sepharose for 4 h.
Co-immunoprecipitated complexes were washed three times with
the same buffer and then analyzed by SDS-PAGE. The protein
concentration was determined by Bradford assay.
Immunoblot Analysis
Immunoblot analysis was performed as previously described
[42]. Briefly, proteins were denatured by incubation at 95uC for
5 min in Laemmli sample buffer. The denatured proteins were
then separated by SDS-PAGE and transferred to nitrocellulose
membranes. After blocking in TTBS buffer (10 mM Tris/HCl,
pH 7.5, 150 mM NaCl and 0.05% Tween 20) containing 5%
skimmed milk powder, the membranes were incubated with
individual monoclonal or polyclonal antibodies and subsequently
reincubated with either anti-mouse or anti-rabbit IgG coupled
with horseradish peroxidase. Detection was performed using an
enhanced chemiluminescence (ECL) kit according to the manu-
facturer’s instructions.
Measurement of PLD Activity in Cells
PLD activity was assayed by measuring the formation of
phosphatidylbutanol (PBtOH), which is the product of PLD-
mediated transphosphatidylation, in the presence of 1-butanol
[12]. Cells were labeled with [3H]myristic acid (10 mCi/ml) for 4 h
and then washed twice with PBS. The labeled cells were
maintained in glucose free-DMEM for 2 h at the indicated
glucose concentrations and then incubated with 0.4% 1-butanol
for 5 min. Next, cells were harvested into 0.8 ml of methanol and
1 M NaCl (1:1) and then mixed with 0.4 ml of chloroform. After
vortexing, the samples were centrifuged at 15,0006g for 1 min, the
organic phase was dried and the lipids were separated using Silica
Gel 60 TLC plate. Finally, the plates were developed with ethyl
acetate/trimethylpentane/acetic acid (9/5/2 = v/v/v). The
amount of [3H]phosphatidyl-butanol was expressed as a percent-
age of the total [3H]-lipid to account for differences in cell labeling
efficiency.
In Vitro Phosphorylation Assay
AMPK was incubated with purified PLD1 (100 ng), GST-
truncated PLD1 fusion mutants (1 mg) or precipitate complexes at
37uC for 15 min in kinase buffer (50 mM Tris/HCl, pH 7.4,
1 mM dithiothreitol, 0.02% Brij-35 and 10 mCi of [c-32P]ATP
(3,000 Ci/mmol)) in the presence of AMP (200 nM). An in vitro
phosphorylation assay was then performed as previously described
[29,43]. The assay was terminated by the addition of 15 ml of
26SDS sample buffer and boiling of the samples for 5 min. The
sample was then subjected to SDS-PAGE and exposed to
photographic film for autoradiography. The protein concentration
was determined by Bradford assay.
In Vivo Phosphorylation Assay
Initially, 16107 HEK-293 cells/100-mm dish were incubated
with 3 mCi of [32P] orthophosphate in 5 ml of phosphate-free
DMEM for 5 h at 37uC. Cells were then washed with PBS and
treated with 50 mM 2-DOG for 10 min. Next, cells were washed
with ice-cold isotonic buffer containing phosphatase inhibitor
(30 mM NaF, 1 mM Na3VO4 and 30 mM Na4O7P2) and then
lysed with 1 ml of lysis buffer (10 mM Tris/HCl, pH 7.5, 1 mM
EDTA, 0.5 mM EGTA and 10 mM NaCl) containing 1% Triton
X-100, 1% cholic acid, protease inhibitors (0.5 mM phenyl-
methylsulfonyl fluoride, 1 mg/ml leupeptin, 5 mg/ml aprotinin)
and phosphatase inhibitors (30 mM NaF, 1 mM Na3VO4 and
30 mM Na4O7P2). After centrifugation (15,0006g for 15 min),
equal amounts of soluble extract were incubated with 2 mg of anti-
PLD antibody and 30 ml of immobilized protein A. The
immunoprecipitated proteins were then separated by SDS-PAGE,
transferred to nitrocellulose membranes and exposed to photo-
graphic film for autoradiography. The protein concentration was
determined by Bradford assay.
Determination of 14C-Glucose Uptake in Cells
C2C12 cells (26105) or L6 GLUT4-myc myoblast cells (26105)
were seeded in a 6-well plate. After differentiation of these cells, no
significant differences of cell numbers were observed in each well.
Morphological changes were confirmed to determine the differ-
entiation. There was no significant cell death or proliferation
during 14C-glucose uptake assay. 14C-glucose uptake was deter-
mined as previously described [26]. Briefly, the differentiated
C2C12 cells or L6 GLUT4-myc myotube cells were serum-starved
for 2 h prior to the assay. Cells were then washed twice with
Krebs-Henseleit buffer (NaCl 118, NaHCO3 25, KCl 4.6, MgSO4
1.2, KH2PO4 1.2 and CaCl2 2.5 mmol/l) and stimulated with or
without the indicated agents. After incubation with 0.1 mCi/ml 2-
deoxy[14C-glucose] at room temperature for 20 min, the uptake of
14C-glucose was terminated by washing cells three times with ice-
cold PBS. Cells were then solubilized with 0.5 N NaOH and 0.1%
SDS and their radioactivities were detected by scintillation
counting. Each value was normalized to the total protein
concentration. After the 14C-glucose uptake assay, the protein
concentration was measured by Bradford assay and no significant
differences were observed among samples. All assays were
performed in duplicate.
Measurement of the Cell Surface GLUT4 in Differentiated
L6 GLUT4-myc Myotube Cells
L6 GLUT4-myc myoblast cells were seeded at 26104 per well
in a 24-well plate. After differentiation of these cells, no significant
differences in cell numbers were among wells. There was also no
significant cell death or proliferation observed during the cell
surface GLUT4 assay. Quantitative analysis of the GLUT4 on the
cell surface was measured by an antibody coupled-colorimetric
absorbance assay, as described previously [44]. Briefly, after
stimulation, cells were exposed to anti-myc antibody (1:100) for
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1 h, fixed with 4% paraformaldehyde (PFA) for 10 min and then
incubated with HRP-conjugated goat anti-rabbit IgG (1:1,000) for
1 h. Next, cells were washed six times with PBS and then 1 ml of
OPD reagent (0.4 mg/ml/o-phenylenediamine dihydrochloride
and 0.4 mg/ml urea hydrogen peroxide) was added to each
sample. The sample was incubated for 30 min at room
temperature and the reaction was then stopped by the addition
of 0.25 ml of 3 N HCl. The optical absorbance of the supernatant
was measured at 492 nm. The background absorbance was
determined using samples incubated in the presence of HRP-
conjugated anti-rabbit IgG alone (without primary antibody) and
then subtracted from the measured values. The protein concen-
tration was measured by Bradford assay after cell surface GLUT4
assay and there were no significant differences observed among
samples. All assays were performed in triplicate.
Statistical Analysis
The results are expressed as the mean 6 SE of data obtained
from the indicated number of experiments performed. Statistical
significance was determined using a Student’s t test.
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